Paramount Group (Paramount Group) Days Sales Outstanding : 7.68 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Paramount Group Days Sales Outstanding?

Paramount Group's average Accounts Receivable for the three months ended in Dec. 2023 was $16.2 Mil. Paramount Group's Revenue for the three months ended in Dec. 2023 was $192.5 Mil. Hence, Paramount Group's Days Sales Outstanding for the three months ended in Dec. 2023 was 7.68.

The historical rank and industry rank for Paramount Group's Days Sales Outstanding or its related term are showing as below:

PGRE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 5.11 Med: 9.39 Max: 10.3
Current: 8.78

During the past 13 years, Paramount Group's highest Days Sales Outstanding was 10.30. The lowest was 5.11. And the median was 9.39.

PGRE's Days Sales Outstanding is ranked better than
75.69% of 617 companies
in the REITs industry
Industry Median: 22.44 vs PGRE: 8.78

Paramount Group's Days Sales Outstanding declined from Dec. 2022 (10.84) to Dec. 2023 (7.68).

Paramount Group Days Sales Outstanding Historical Data

The historical data trend for Paramount Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paramount Group Days Sales Outstanding Chart

Paramount Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

9.65

9.39

8.31

9.72

10.30

Paramount Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															10.84	10.48	8.75	6.76	7.68

Competitive Comparison of Paramount Group's Days Sales Outstanding

For the REIT - Office subindustry, Paramount Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paramount Group's Days Sales Outstanding Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Paramount Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Paramount Group's Days Sales Outstanding falls into.

Paramount Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Paramount Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (23.866	+	18.053)	/	2 )	/	742.788	*	365
=	20.9595					/	742.788	*	365
=	10.30

Paramount Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (14.34	+	18.053)	/	2 )	/	192.471	*	365 / 4
=	16.1965					/	192.471	*	365 / 4
=	7.68

Paramount Group (NYSE:PGRE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Paramount Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Paramount Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Paramount Group (Paramount Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Paramount Group Inc (NYSE:PGRE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

6PM:Germany

Address

1633 Broadway, Suite 1801, New York, NY, USA, 10019

Website

https://www.pgre.com

Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district ("CBD") submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. Paramount Group derives nearly all of its revenue in the form of rental income from leasing its offices to tenants. The company's New York City assets generate the majority of its total revenue.

Executives

Albert P. Behler	director, officer: Chairman, CEO and President	PARAMOUNT GROUP, INC., 1633 BROADWAY, SUITE 1801, NEW YORK NY 10019
Gage R. Johnson	officer: SVP, GC and Secretary	PARAMOUNT GROUP, INC., 1633 BROADWAY, NEW YORK NY 10018
Thomas Armbrust	director	WERNER OTTO STRASSE 1-7, D-22179 HAMBURG 2M D-22179
Martin Bussmann	director	C/O PARAMOUNT GROUP, INC., 1633 BROADWAY, SUITE 1801, NEW YORK NY 10019
Paula Sutter	director	969 BROADWAY, SUITE 200, OAKLAND CA 94607
Hitoshi Saito	director	PARAMOUNT GROUP, INC., 1633 BROADWAY, SUITE 1801, NEW YORK NY 10019
Ermelinda Berberi	officer: See Remarks	1633 BROADWAY, SUITE 1801, NEW YORK NY 10019
Gregory S Wright	director	FOUR EMBARCADERO CENTER, SUITE 3200, SAN FRANCISCO CA 94111
Katharina Otto-bernstein	director, 10 percent owner	C/O KG CURA VERMOGENSVERWALTUNG G.M.B.H., WANDSBEKER STR. 3-7, HAMBURG 2M 22179
Alexander Otto	10 percent owner	C/O KG CURA VERMOGENSVERWALTUNG G.M.B.H., WANDSBEKER STR. 3-7, HAMBURG 2M 22179
Maren Otto	10 percent owner	WERNER-OTTO-STR. 1-7, HAMBURG 2M D-22179
Dyer Colin	director	JONES LANG LASALLE INCORPORATED, 200 EAST RANDOLPH DRIVE, CHICAGO IL 60601
David Zobel	officer: See Remarks	144 E. 84TH STREET #6D, NEW YORK NY 10028
Mark R Patterson	director	40 MINNISINK ROAD, SHORT HILLS NJ 07078
Brindley Peter R.c.	officer: EVP, Leasing	1633 BROADWAY, SUITE 1801, NEW YORK NY 10019